Piyada Supasa

11.9k total citations · 1 hit paper
12 papers, 1.0k citations indexed

About

Piyada Supasa is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Piyada Supasa has authored 12 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 8 papers in Public Health, Environmental and Occupational Health and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Piyada Supasa's work include Mosquito-borne diseases and control (8 papers), Viral Infections and Vectors (7 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Piyada Supasa is often cited by papers focused on Mosquito-borne diseases and control (8 papers), Viral Infections and Vectors (7 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Piyada Supasa collaborates with scholars based in Thailand, United Kingdom and United States. Piyada Supasa's co-authors include Juthathip Mongkolsapaya, Gavin Screaton, Wanwisa Dejnirattisai, Wiyada Wongwiwat, Prida Malasit, F.A. Rey, Giovanna Barba–Spaeth, Alexander Rouvinski, Thaneeya Duangchinda and Anavaj Sakuntabhai and has published in prestigious journals such as Nature Medicine, Nature Communications and Nature Immunology.

In The Last Decade

Piyada Supasa

11 papers receiving 995 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus

2016 663 citations Wanwisa Dejnirattisai, Piyada Supasa et al. Nature Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Piyada Supasa Thailand	7	882	779	249	108	83	12	1.0k
Guillermo Comach Venezuela	20	796 0.9×	608 0.8×	215 0.9×	69 0.6×	58 0.7×	46	1000
Wahala M. P. B. Wahala United States	7	1.0k 1.1×	868 1.1×	108 0.4×	102 0.9×	31 0.4×	7	1.1k
Akhilesh Chandra Mishra India	14	1.0k 1.2×	1.0k 1.3×	157 0.6×	77 0.7×	25 0.3×	36	1.3k
Rose M. Langsjoen United States	12	660 0.7×	631 0.8×	188 0.8×	70 0.6×	21 0.3×	16	770
James Duehr United States	10	559 0.6×	590 0.8×	232 0.9×	53 0.5×	36 0.4×	18	743
Derek Wallace United States	16	1.2k 1.4×	937 1.2×	81 0.3×	112 1.0×	67 0.8×	32	1.3k
Alienys Izquierdo Cuba	14	864 1.0×	659 0.8×	108 0.4×	73 0.7×	42 0.5×	21	973
Magelda Montoya United States	11	767 0.9×	671 0.9×	90 0.4×	52 0.5×	92 1.1×	15	829
Iris Medits Austria	9	455 0.5×	486 0.6×	140 0.6×	67 0.6×	23 0.3×	11	601
Fabrizio Carletti Italy	15	660 0.7×	638 0.8×	148 0.6×	48 0.4×	24 0.3×	43	933

Countries citing papers authored by Piyada Supasa

Since Specialization

Citations

This map shows the geographic impact of Piyada Supasa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piyada Supasa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piyada Supasa more than expected).

Fields of papers citing papers by Piyada Supasa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piyada Supasa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piyada Supasa. The network helps show where Piyada Supasa may publish in the future.

Co-authorship network of co-authors of Piyada Supasa

This figure shows the co-authorship network connecting the top 25 collaborators of Piyada Supasa. A scholar is included among the top collaborators of Piyada Supasa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piyada Supasa. Piyada Supasa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Nissley, Daniel A., Daniel B. Wilson, Mikhail A. Kutuzov, et al.. (2025). The molecular reach of antibodies crucially underpins their viral neutralisation capacity. Nature Communications. 16(1). 338–338. 2 indexed citations

Asor, Roi, Anna Olerinyova, Sean A. Burnap, et al.. (2024). Cooperativity and induced oligomerization control the interaction of SARS-CoV-2 with its cellular receptor and patient-derived antibodies. Biophysical Journal. 123(3). 313a–313a. 1 indexed citations

Liu, Chang, Raksha Das, Aiste Dijokaite-Guraliuc, et al.. (2024). Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection. Nature Communications. 15(1). 3284–3284. 11 indexed citations

Zhou, Daming, Piyada Supasa, Chang Liu, et al.. (2024). The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86. Nature Communications. 15(1). 2734–2734. 6 indexed citations

Scherwitzl, Iris, Piyada Supasa, Wanwisa Dejnirattisai, et al.. (2024). The alteration of NK cells phenotypes related to the functions and dengue disease outcomes. Virus Research. 345. 199382–199382. 2 indexed citations

Keelapang, Poonsook, Piyada Supasa, Rungtawan Sriburi, et al.. (2022). A group of infection-enhancing and focus size-reducing monoclonal antibodies recognized an ‘a and c’ strands epitope in the pr domain of Dengue Virus prM. Virus Research. 323. 199015–199015.

Abbink, Peter, Rafael A. Larocca, Wanwisa Dejnirattisai, et al.. (2018). Therapeutic and protective efficacy of a dengue antibody against Zika infection in rhesus monkeys. Nature Medicine. 24(6). 721–723. 32 indexed citations

Renner, Max, Aleksandra Flanagan, Wanwisa Dejnirattisai, et al.. (2018). Characterization of a potent and highly unusual minimally enhancing antibody directed against dengue virus. Nature Immunology. 19(11). 1248–1256. 30 indexed citations

Montoya, Magelda, Matthew H. Collins, Wanwisa Dejnirattisai, et al.. (2018). Longitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and Dengue Virus Infection in Asia and the Americas. The Journal of Infectious Diseases. 218(4). 536–545. 108 indexed citations

10.

Fernández, Estefanı́a, Wanwisa Dejnirattisai, Bin Cao, et al.. (2017). Human antibodies to the dengue virus E-dimer epitope have therapeutic activity against Zika virus infection. Nature Immunology. 18(11). 1261–1269. 87 indexed citations

11.

Rouvinski, Alexander, Wanwisa Dejnirattisai, Pablo Guardado‐Calvo, et al.. (2017). Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope. Nature Communications. 8(1). 15411–15411. 64 indexed citations

12.

Dejnirattisai, Wanwisa, Piyada Supasa, Wiyada Wongwiwat, et al.. (2016). Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus. Nature Immunology. 17(9). 1102–1108. 663 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact